Hinweis zur angezeigten Sprache

Diese Seite ist nicht in der von Ihnen gewählten Sprache über den maschinellen Übersetzungsdienst auf dieser Website verfügbar.
Sie wird in der englischen Originalversion angezeigt.

What’s new

Find all new and updated information published on our website in one place below. Filters are available to narrow results down based on your interests, such as whether it relates to human or veterinary medicines or specific topics. Information on medicines and related procedures includes a reference to relevant substances: INN or common name, active substance, and English common name for herbal products. This overview covers up to two months back.

As of 1 October 2025, information on medicines and related procedures includes a reference to relevant substances: INN or common name, active substance, and English common name for herbal products.

On 29 September 2026, we updated the search paths shown in your browser's address bar to make them easier to read and understand. As a result, links to search results that you previously bookmarked may no longer work. We advise you to carry out your search again.

Results (67)

Date	Content	Status
05/10/2026	Medicine: Byooviz ranibizumab	Updated
05/10/2026	Medicine: Ertapenem SUN ertapenem	Updated
05/10/2026	Medicine: Kinzalkomb telmisartan; hydrochlorothiazide	Updated
05/10/2026	Medicine: PritorPlus telmisartan; hydrochlorothiazide	Updated
05/10/2026	Medicine: Aumseqa Aumolertinib	Updated
05/10/2026	Medicine: Aimovig erenumab	Updated
05/10/2026	Event: Committee for Medicinal Products for Human Use (CHMP): 15-18 September 2025	Updated
05/10/2026	Document: Annex to 15-18 September 2025 CHMP minutes	New
05/10/2026	Document: Minutes of the CHMP meeting 15-18 September 2025	New
05/10/2026	Medicine: Hexacima diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA), poliomyelitis (inactivated) and Haemophilus influenzae type b conjugate vaccine (adsorbed)	Updated
05/10/2026	PSUSA: PSUSA/00011084/202603 - periodic safety update report single assessment dienogest / ethinylestradiol	New
05/10/2026	Medicine: Hexyon diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA), poliomyelitis (inactivated) and Haemophilus influenzae type b conjugate vaccine (adsorbed)	Updated
05/10/2026	Medicine: Opdualag relatlimab; nivolumab	Updated
05/10/2026	PSUSA: PSUSA/00000110/202601 - periodic safety update report single assessment alprostadil	New
05/10/2026	Document: Minutes of the CAT meeting 12-14 August 2026	New
05/10/2026	Document: Minutes of the CAT meeting 15-17 July 2026	New
05/10/2026	Document: User manual for the eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) user interface (XEVMPDweb)	Updated
05/10/2026	Event: Second HMA/EMA multi-stakeholder forum on EudraVigilance and signal detection	Updated
05/10/2026	Event: First European Medicines Agency (EMA) - International Society for Cell and Gene Therapy (ISCT) bilateral meeting	Updated
02/10/2026	PSUSA: PSUSA/00002550/202601 - periodic safety update report single assessment propafenone	New
02/10/2026	Medicine: Orgovyx relugolix	Updated
02/10/2026	Medicine: Ziextenzo pegfilgrastim	Updated
02/10/2026	Event: Regulatory sandboxes: Joint European Commission (EC) / European Medicines Agency (EMA) multi-stakeholder workshop	Updated
02/10/2026	Medicine: Arsenic trioxide Accord arsenic trioxide	Updated
02/10/2026	PIP: EMA/PE/0000302950 - paediatric investigation plan humanised IgG4 bispecific antibody against programmed cell death protein 1 and vascular endothelial growth factor A, long form	New
02/10/2026	PIP: EMA/PE/0000291645 - paediatric investigation plan mRNA encoding Human cytomegalovirus UL128; mRNA encoding Human cytomegalovirus UL130; mRNA encoding Human cytomegalovirus UL131A; mRNA encoding Human cytomegalovirus glycoprotein H; mRNA encoding Human cytomegalovirus glycoprotein B; mRNA encoding Human cytomegalovirus glycoprotein L	Updated
02/10/2026	Medicine: Rasilez aliskiren	Updated
02/10/2026	PIP: EMA/PE/0000261512 - paediatric investigation plan Dexamethasone sodium phosphate encapsulated in human autologous erythrocytes	Updated
02/10/2026	Medicine: Ordspono odronextamab	Updated
02/10/2026	Medicine: Sialanar glycopyrronium bromide	Updated
02/10/2026	Medicine: Andembry garadacimab	Updated
02/10/2026	Medicine: Fymskina ustekinumab	Updated
02/10/2026	Medicine: Sprycel dasatinib (anhydrous)	Updated
02/10/2026	Page: Procedural timetables	Updated
02/10/2026	Event: Committee for Herbal Medicinal Products (HMPC): 6-8 July 2026	Updated
02/10/2026	Document: Minutes of the HMPC meeting 6-8 July 2026	New
02/10/2026	Document: List of centrally authorised products with safety-related changes to the product information	Updated
02/10/2026	News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 28 September - 1 October	New
02/10/2026	Medicine: Itvisma onasemnogene abeparvovec	Updated
02/10/2026	Medicine: Bysumlog insulin lispro	Updated
02/10/2026	EU-M4all: Ivermectin/Albendazole - opinion on medicine for use outside EU ivermectin; albendazole	Updated
02/10/2026	Event: Good manufacturing practice: Multistakeholder workshop on expert contributions to artificial intelligence guidance development (Annex 22)	Updated
02/10/2026	Medicine: Riltrava Aerosphere formoterol fumarate dihydrate; glycopyrronium; budesonide	Updated
02/10/2026	Medicine: Leqvio inclisiran	Updated
02/10/2026	Medicine: Ebvallo tabelecleucel	Updated
02/10/2026	Page: External whistleblowing policy	Updated
02/10/2026	Medicine: Byetta exenatide	Updated
02/10/2026	Document: Policy 0072: Policy on the handling of information from external persons on breaches related to the authorisation, supervision and maintenance of human and veterinary medicinal products or other EMA activities	Updated
02/10/2026	Medicine: Bydureon exenatide	Updated
02/10/2026	Medicine: Adzynma rADAMTS13	Updated
01/10/2026	Medicine: Constella linaclotide	Updated
01/10/2026	Medicine: Sibnayal potassium citrate; potassium hydrogen carbonate	Updated
01/10/2026	Event: Meeting of the Medicine Shortages Single Point of Contact (SPOC) Working Party	Updated
01/10/2026	Document: Meeting summary - Medicine shortages SPOC working party meeting 15 July 2026	New
01/10/2026	Medicine: Degevma denosumab	Updated
01/10/2026	Event: European Medicines Agency workshop on bacteriophage therapy	New
01/10/2026	Event: Seventeenth meeting of the industry stakeholder platform on the operation of the centralised procedure for human medicines	New
01/10/2026	News: Advice on ‘end-of-year’ submission dates for type I variations in 2026	New
01/10/2026	News: EMA Management Board: highlights of September 2026 meeting	New
01/10/2026	Document: Proceedings for the nomination and appointment of the next EMA Executive Director	New
01/10/2026	Medicine: Epruvy (previously Ranibizumab Midas) ranibizumab	Updated
01/10/2026	Page: International Coalition of Medicines Regulatory Authorities (ICMRA)	Updated
01/10/2026	News: Global regulators call for advancing alternatives to animal testing across the medicine lifecycle	New
01/10/2026	Page: EudraVigilance: electronic reporting	Updated
01/10/2026	News: Executive Director speech at EMA women’s health multi-stakeholder workshop	New
01/10/2026	Medicine: Pomalidomide Teva pomalidomide	Updated
01/10/2026	Medicine: Lucentis ranibizumab	Updated

What’s new

Filter by

Results (67)